Nrc Health (NRC) Common Equity (2010 - 2026)

Nrc Health's Common Equity history runs 17 years deep, the most recent figure standing at $13.5 million for Q1 2026.

• In Q1 2026, Common Equity fell 54.52% year-over-year to $13.5 million; the TTM figure through Mar 2026 stood at $13.5 million (down 54.52% YoY), while the FY2025 annual figure was $14.0 million, down 55.28% from the prior year.
• Common Equity came in at $13.5 million for Q1 2026 at Nrc Health, down from $14.0 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $81.5 million in Q1 2022 to a low of $13.5 million in Q1 2026.
• A 5-year average of $46.2 million and a median of $40.2 million in 2024 frame the typical range for Common Equity.
• Across the five-year window, Common Equity climbed 13.3% in 2023 and sank 58.66% in 2025, its largest moves.
• Nrc Health's Common Equity stood at $72.0 million in 2022, then tumbled by 32.04% to $49.0 million in 2023, then tumbled by 36.1% to $31.3 million in 2024, then sank by 55.28% to $14.0 million in 2025, then dropped by 3.54% to $13.5 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $13.5 million, $14.0 million, and $14.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison